You are here

Article Text

Article menu
Download PDFPDF
Adult nursing
Mixed methods study
Small study finds that 3 years after prostate cancer treatment, men may report high quality of life and functioning
  1. Jeffrey Albaugh
  1. NorthShore University HealthCare, Chicago, Illinois, USA
  1. Correspondence to: Dr Jeffrey Albaugh
    NorthShore University HealthCare, 2180 Pfingsten Road, Suite 3000, Chicago, IL 60631, USA; jjalbaugh{at}yahoo.com

https://doi.org/10.1136/eb-2013-101420

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Jakobsson L, Persson L, Lundqvist P . Daily life and life quality 3 years following prostate cancer treatment. BMC Nurs 2013;12:11.OpenUrlCrossRefPubMed

    Implications for practice and research

    • The male patients in this study reported high levels of quality of life, with high ratings for overall physical functioning and health. They appeared to adjust to the diminished sexual function.

    • Nurses can use these outcomes and the results from other studies to inform patients.

    • Nurses should understand that each individual will have a different prediagnosis level of and valuation of sexual activity/function.

    • Further multicentred large studies are needed.

    • Nurses can provide patient education about common sexual problems encountered post prostate cancer treatment and the options for addressing those issues.

    Context

    Prostate cancer is the most common non-skin cancer in men and quality of life continues to be a major focus of men after …

    View Full Text

    Footnotes

    • Competing interests JA has received royalties for his book ‘Reclaiming sex & intimacy after prostate cancer treatment’ with Anthony Jannetti Publishing and has acted on the Advisory Board/Speaker Bureau for Actient pharmaceutical/TIMM Medical.